239 related articles for article (PubMed ID: 28188341)
1. Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.
Parmentier C; Couttet P; Wolf A; Zaccharias T; Heyd B; Bachellier P; Uteng M; Richert L
Arch Toxicol; 2017 Aug; 91(8):2879-2893. PubMed ID: 28188341
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures.
Parmentier C; Truisi GL; Moenks K; Stanzel S; Lukas A; Kopp-Schneider A; Alexandre E; Hewitt PG; Mueller SO; Richert L
Drug Metab Dispos; 2013 Oct; 41(10):1835-42. PubMed ID: 23913027
[TBL] [Abstract][Full Text] [Related]
3. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.
Parmentier C; Hendriks DFG; Heyd B; Bachellier P; Ingelman-Sundberg M; Richert L
Toxicol Lett; 2018 Oct; 295():187-194. PubMed ID: 29913214
[TBL] [Abstract][Full Text] [Related]
4. Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Van den Hof WFPM; Coonen MLJ; van Herwijnen M; Brauers K; Jennen D; Olde Damink SWM; Schaap FG; Kleinjans JCS
Toxicol In Vitro; 2017 Oct; 44():322-329. PubMed ID: 28778767
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic Analysis of Cholestatic Compounds In Vitro.
Parmentier C; Couttet P; Uteng M; Wolf A; Richert L
Methods Mol Biol; 2019; 1981():175-186. PubMed ID: 31016655
[TBL] [Abstract][Full Text] [Related]
6. Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis.
Wolters JE; van Herwijnen MH; Theunissen DH; Jennen DG; Van den Hof WF; de Kok TM; Schaap FG; van Breda SG; Kleinjans JC
Chem Res Toxicol; 2016 Dec; 29(12):2164-2174. PubMed ID: 27989131
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Oorts M; Baze A; Bachellier P; Heyd B; Zacharias T; Annaert P; Richert L
Toxicol In Vitro; 2016 Aug; 34():179-186. PubMed ID: 27046439
[TBL] [Abstract][Full Text] [Related]
8. Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes.
Jetten MJ; Ruiz-Aracama A; Coonen ML; Claessen SM; van Herwijnen MH; Lommen A; van Delft JH; Peijnenburg AA; Kleinjans JC
Arch Toxicol; 2016 May; 90(5):1103-15. PubMed ID: 26104854
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
Chatterjee S; Richert L; Augustijns P; Annaert P
Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
[TBL] [Abstract][Full Text] [Related]
10. Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices.
Vatakuti S; Pennings JL; Gore E; Olinga P; Groothuis GM
Chem Res Toxicol; 2016 Mar; 29(3):342-51. PubMed ID: 26881866
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture.
Oorts M; Richert L; Annaert P
J Pharmacol Toxicol Methods; 2015; 73():63-71. PubMed ID: 25828992
[TBL] [Abstract][Full Text] [Related]
12. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
13. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
[TBL] [Abstract][Full Text] [Related]
14. Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach.
Vatakuti S; Olinga P; Pennings JLA; Groothuis GMM
Arch Toxicol; 2017 Mar; 91(3):1401-1412. PubMed ID: 27344345
[TBL] [Abstract][Full Text] [Related]
15. Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes.
Szalowska E; Stoopen G; Groot MJ; Hendriksen PJ; Peijnenburg AA
BMC Med Genomics; 2013 Oct; 6():39. PubMed ID: 24112857
[TBL] [Abstract][Full Text] [Related]
16. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
[TBL] [Abstract][Full Text] [Related]
17. Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids.
González R; Cruz A; Ferrín G; López-Cillero P; Briceño J; Gómez MA; Rufián S; Padillo J; De la Mata M; Marin JJ; Muntané J
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):740-50. PubMed ID: 21526375
[TBL] [Abstract][Full Text] [Related]
18. Promising toxicological biomarkers for the diagnosis of liver injury types: Bile acid metabolic profiles and oxidative stress marker as screening tools in drug development.
Masubuchi N; Nishiya T; Imaoka M; Mizumaki K; Okazaki O
Chem Biol Interact; 2016 Aug; 255():74-82. PubMed ID: 26365562
[TBL] [Abstract][Full Text] [Related]
19. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes.
Li X; Liu R; Yu L; Yuan Z; Sun R; Yang H; Zhang L; Jiang Z
Toxicology; 2016 Aug; 370():106-115. PubMed ID: 27702592
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]